Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:PAYX News 10 July 2025 - 10 January 2026

Boss’s Day Bombshell: 75% of Employees Actually LIKE Their Boss – New Survey Shatters Stereotypes

Boss’s Day Bombshell: 75% of Employees Actually LIKE Their Boss – New Survey Shatters Stereotypes

New Survey Shatters “Bad Boss” Myth A newly released GroupTogether study finds that most employees hold surprisingly warm feelings for their managers einpresswire.com. “I was surprised that three-quarters of people like their boss; it proves the clichéd stereotype of people hating their boss is outdated,” says Ali Linz, Co-Founder of GroupTogether einpresswire.com. The survey (1,260 U.S. respondents, Sep 2025) shows 75.9% “like” their boss and only a small minority report disliking them einpresswire.com. This flips the script on the old punchline of “hate your boss” jokes. Instead of fear or hatred, workers highlighted positive attributes of their managers. The most
14 October 2025
··
Global HCM Software Market Update (June–July 2025) – Key Trends, News & Forecasts

Global HCM Software Market Update (June–July 2025) – Key Trends, News & Forecasts

The global HR/HCM and payroll software market is projected to grow from about $35.3 billion in 2024 to $57.8 billion in 2029 and reach $91.7 billion by 2034, a roughly 10% annual growth rate. North America accounts for 36% of market revenue, while Asia-Pacific is the fastest-growing region with a forecast around 12% CAGR. The SMB/SME segment is expected to expand about 13% annually through 2029, outpacing large-enterprise growth. The market remains highly fragmented, with the top 10 vendors capturing only about 10% of global revenue in 2023, including Oracle, SAP, ADP, Sage, Paychex, UKG, and Paycom at roughly 1–2%
10 July 2025
········

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Go toTop